Results 141 to 150 of about 11,792,242 (280)

'There's No Improvement. I'm Still Bedridden': Recovery After Hospital Admission for Low Back Pain and Alignment With Patient Expectations. [PDF]

Musculoskeletal Care
Orlando JF, Beard M, Burke ALJ, Guerin M, Kumar S.   +4 more
europepmc   +1 more source

Florence Nightingale’s Influence on Hospital Design, Hospitalism, Hospital Diseases, and Hospital Architects [PDF]

HERD: Health Environments Research & Design Journal, 2020
openaire   +2 more sources

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Predictors of Hospital Admission Following Emergency Department Presentation for Falls Among Older Adults: A Retrospective Analysis. [PDF]

Australas J Ageing
Kim YJ, Shin HS, Jang K.
europepmc   +1 more source

Hospital Dietetics [PDF]

Proceedings of the Nutrition Society, 1947
D M, LYON, R, PYBUS
openaire   +2 more sources

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Examining HbA1c in Frail Older Adults: A Linked Data Cohort Study. [PDF]

Australas J Ageing
Meyerowitz-Katz G, McDonagh J, William S, John R, Hng TM, McLean M, Bul M, Lindley RI, Ferguson C.   +8 more
europepmc   +1 more source

GUY'S HOSPITAL. [PDF]

The Lancet
openaire   +6 more sources

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Severity of Illness and Mortality According to Time of Admission to Intensive Care. [PDF]

Acta Anaesthesiol Scand
Ihalainen V, Pölkki A, Bendel S, Hästbacka J, Heino S, Reinikainen M, FINNICU Research Group.   +6 more
europepmc   +1 more source